U2AF1 and myelodysplastic syndrome: A meta-analysis covering 3038 patients from 13 studies showed that U2AF1 mutations were associated with poor survival in MDS patients, and patients with U2AF1Q157 had a worse OS than those with U2AF1S34 (Li et al., 2020).